_version_ 1784780082119704576
author Ionova, T.
Vinogradova, O.
Markova, E.
Mukha, L.
Novitskaya, N.
Pankrashkina, M.
Shelekhova, T.
Sherstnev, D.
Proydakov, A.
Lyurova, E.
Pospelova, T.
Babaeva, T.
Bulieva, N.
Kuchma, G.
Andreevskaya, E.
Frolova, M.
Zinina, E.
Trizna, K.
Shestopalova, I.
Shneyder, T.
Khvorostenko, L.
Kuchin, A.
Mulina, I.
Volkova, S.
Zakharov, S.
Porfirieva, N.
Nikitina, T.
Gritsaev, S.
author_facet Ionova, T.
Vinogradova, O.
Markova, E.
Mukha, L.
Novitskaya, N.
Pankrashkina, M.
Shelekhova, T.
Sherstnev, D.
Proydakov, A.
Lyurova, E.
Pospelova, T.
Babaeva, T.
Bulieva, N.
Kuchma, G.
Andreevskaya, E.
Frolova, M.
Zinina, E.
Trizna, K.
Shestopalova, I.
Shneyder, T.
Khvorostenko, L.
Kuchin, A.
Mulina, I.
Volkova, S.
Zakharov, S.
Porfirieva, N.
Nikitina, T.
Gritsaev, S.
author_sort Ionova, T.
collection PubMed
description
format Online
Article
Text
id pubmed-9431535
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94315352022-08-31 PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING Ionova, T. Vinogradova, O. Markova, E. Mukha, L. Novitskaya, N. Pankrashkina, M. Shelekhova, T. Sherstnev, D. Proydakov, A. Lyurova, E. Pospelova, T. Babaeva, T. Bulieva, N. Kuchma, G. Andreevskaya, E. Frolova, M. Zinina, E. Trizna, K. Shestopalova, I. Shneyder, T. Khvorostenko, L. Kuchin, A. Mulina, I. Volkova, S. Zakharov, S. Porfirieva, N. Nikitina, T. Gritsaev, S. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431535/ http://dx.doi.org/10.1097/01.HS9.0000852060.15771.ed Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Ionova, T.
Vinogradova, O.
Markova, E.
Mukha, L.
Novitskaya, N.
Pankrashkina, M.
Shelekhova, T.
Sherstnev, D.
Proydakov, A.
Lyurova, E.
Pospelova, T.
Babaeva, T.
Bulieva, N.
Kuchma, G.
Andreevskaya, E.
Frolova, M.
Zinina, E.
Trizna, K.
Shestopalova, I.
Shneyder, T.
Khvorostenko, L.
Kuchin, A.
Mulina, I.
Volkova, S.
Zakharov, S.
Porfirieva, N.
Nikitina, T.
Gritsaev, S.
PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
title PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
title_full PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
title_fullStr PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
title_full_unstemmed PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
title_short PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
title_sort pb2308: quality of life and clinical outcomes in adult patients with chronic immune thrombocytopenia (citp) during treatment with romiplostim in a real-world setting
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431535/
http://dx.doi.org/10.1097/01.HS9.0000852060.15771.ed
work_keys_str_mv AT ionovat pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT vinogradovao pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT markovae pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT mukhal pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT novitskayan pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT pankrashkinam pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT shelekhovat pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT sherstnevd pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT proydakova pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT lyurovae pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT pospelovat pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT babaevat pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT bulievan pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT kuchmag pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT andreevskayae pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT frolovam pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT zininae pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT triznak pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT shestopalovai pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT shneydert pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT khvorostenkol pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT kuchina pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT mulinai pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT volkovas pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT zakharovs pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT porfirievan pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT nikitinat pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT gritsaevs pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting